Log in

NASDAQ:GCAN - The Greater Cannabis Stock Price, Forecast & News

$0.04
0.00 (-10.00 %)
(As of 12/13/2019 01:16 AM ET)
Today's Range
$0.04
Now: $0.04
$0.04
50-Day Range N/A
52-Week Range
$0.02
Now: $0.04
$0.34
Volume172,960 shs
Average Volume286,971 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
The Greater Cannabis Company, Inc., a biopharmaceutical company, focuses on the development and commercialization of cannabinoid delivery systems. It holds the license of Eluting Transmucosal Patch platform for non-invasive drug delivery in the cannabis field. The company is based in Baltimore, Maryland.

Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GCAN
CUSIPN/A
CIKN/A
Phone443-738-4051

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2
Next Earnings DateN/A
OptionableNot Optionable

Receive GCAN News and Ratings via Email

Sign-up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.


The Greater Cannabis (NASDAQ:GCAN) Frequently Asked Questions

What is The Greater Cannabis' stock symbol?

The Greater Cannabis trades on the NASDAQ under the ticker symbol "GCAN."

Has The Greater Cannabis been receiving favorable news coverage?

Media coverage about GCAN stock has been trending extremely negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. The Greater Cannabis earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for The Greater Cannabis.

Who are some of The Greater Cannabis' key competitors?

Who are The Greater Cannabis' key executives?

The Greater Cannabis' management team includes the folowing people:
  • Mr. Aitan Zacharin, Chairman, Pres, CEO, Acting CFO & Treasurer (Age 36)
  • Mr. Mark Frederick Radom, Chief Legal Officer, VP & Gen. Counsel (Age 51)

How do I buy shares of The Greater Cannabis?

Shares of GCAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is The Greater Cannabis' stock price today?

One share of GCAN stock can currently be purchased for approximately $0.04.

What is The Greater Cannabis' official website?

The official website for The Greater Cannabis is http://www.gcanrx.com/.

How can I contact The Greater Cannabis?

The company can be reached via phone at 443-738-4051.


MarketBeat Community Rating for The Greater Cannabis (NASDAQ GCAN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about The Greater Cannabis and other stocks. Vote "Outperform" if you believe GCAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GCAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel